![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Open AccessEuropean LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia
The therapeutic landscape of chronic myeloid leukemia (CML) has profoundly changed over the past 7 years. Most patients with chronic phase (CP) now have a normal life expectancy. Another goal is achieving a st...
-
Article
Determinanten gesundheitsbezogener Lebensqualität bei systemischem Lupus erythematodes: eine monozentrische, retrospektive Langzeitobservationsstudie in Deutschland
Die Verbesserung der gesundheitsbezogenen Lebensqualität (HRQoL) ist ein übergeordnetes Behandlungsziel beim systemischen Lupus erythematodes (SLE). Patientendaten mit wiederholten HRQoL-Messungen aus unserer ...
-
Article
Eosinophilie bei pulmonalen Infektionen
Neben Allergien, Autoimmunerkrankungen, Vaskulitiden, Dermatosen, Malignomen und Medikamentennebenwirkungen können sowohl parasitäre als auch nichtparasitäre Infektionen Ursachen für eine Eosinophilie sein. Be...
-
Article
Open AccessInterleukin 4 induces apoptosis of acute myeloid leukemia cells in a Stat6-dependent manner
Cytokines provide signals that regulate immature normal and acute myeloid leukemia (AML) cells in the bone marrow microenvironment. We here identify interleukin 4 (IL4) as a selective inhibitor of AML cell gro...
-
Article
Differences between BCL2-break positive and negative follicular lymphoma unraveled by whole-exome sequencing
Depending on disease stage follicular lymphoma (FL) lack the t(14;18) in ~15–~50% of cases. Nevertheless, most of these cases express BCL2. To elucidate mechanisms triggering BCL2 expression and promoting path...
-
Article
Open AccessNo increased prevalence of malignancies among first-degree relatives of 800 patients with chronic myeloid leukemia: a population-based study in Sweden
-
Article
Open AccessIncreased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia
Recent studies suggest that a proportion of chronic myeloid leukemia (CML) patients in deep molecular remission can discontinue the tyrosine kinase inhibitor (TKI) treatment without disease relapse. In this mu...
-
Article
Open AccessInactivation of the putative ubiquitin-E3 ligase PDLIM2 in classical Hodgkin and anaplastic large cell lymphoma
Apart from its unique histopathological appearance with rare tumor cells embedded in an inflammatory background of bystander cells, classical Hodgkin lymphoma (cHL) is characterized by an unusual activation of...
-
Article
Safety and efficacy of the combination of pegylated interferon-α2b and dasatinib in newly diagnosed chronic-phase chronic myeloid leukemia patients
Dasatinib (DAS) and interferon-α have antileukemic and immunostimulatory effects and induce deep responses in chronic myeloid leukemia (CML). We assigned 40 newly diagnosed chronic-phase CML patients to receiv...
-
Article
Open AccessThe concept of treatment-free remission in chronic myeloid leukemia
The advent of tyrosine kinase inhibitors (TKI) into the management of patients with chronic myeloid leukemia (CML) has profoundly improved prognosis. Survival of responders is approaching that of the general p...
-
Article
Increased prevalence of prior malignancies and autoimmune diseases in patients diagnosed with chronic myeloid leukemia
We recently reported an increased incidence of second malignancies in chronic myeloid leukemia (CML) patients treated with tyrosine kinase inhibitors (TKI). To elucidate whether this increase may be linked, no...
-
Article
IL1RAP expression as a measure of leukemic stem cell burden at diagnosis of chronic myeloid leukemia predicts therapy outcome
-
Article
Analysis of mutational signatures in exomes from B-cell lymphoma cell lines suggest APOBEC3 family members to be involved in the pathogenesis of primary effusion lymphoma
-
Article
The mutational pattern of primary lymphoma of the central nervous system determined by whole-exome sequencing
To decipher the mutational pattern of primary CNS lymphoma (PCNSL), we performed whole-exome sequencing to a median coverage of 103 × followed by mutation verification in 9 PCNSL and validation using Sanger se...
-
Article
A B-cell epigenetic signature defines three biologic subgroups of chronic lymphocytic leukemia with clinical impact
Prospective identification of patients with chronic lymphocytic leukemia (CLL) destined to progress would greatly facilitate their clinical management. Recently, whole-genome DNA methylation analyses identifie...
-
Article
Placental Schistosoma haematobium infection in a German returnee from Malawi
Schistosomiasis is a widespread helminthic infection which sometimes may affect travelers to endemic areas. We report on a case of urogenital and placental schistosomiasis in a 28-year-old German woman who had...
-
Article
Möglichkeiten und Grenzen patientenberichteter Endpunkte am Beispiel des systemischen Lupus erythematodes und der LuLa-Studie
Patientenberichtete Endpunkte bzw. „patient-reported outcomes“ (PRO) haben in den letzten drei Jahrzehnten eine zunehmende Bedeutung in der Beurteilung von Krankheitsverläufen und Therapieansprechen erfahren. ...
-
Article
55-jährige Patientin mit Husten, Fieber, Gelenkschwellungen und Exanthem nach einem Urlaub in Ecuador
Eine 55-jährige Patientin stellte sich 16 Monate nach Aufenthalt in Ecuador mit einem unklaren Lungenbefund vor. Es bestanden Nachtschweiß und allgemeine Schwäche. In der Computertomographie zeigte sich ein 14...
-
Article
RNA-seq identifies clinically relevant fusion genes in leukemia including a novel MEF2D/CSF1R fusion responsive to imatinib
-
Article
Open AccessBase-pair resolution DNA methylome of the EBV-positive Endemic Burkitt lymphoma cell line DAUDI determined by SOLiD bisulfite-sequencing